- Home
- BMEA vs PFO Comparison
BMEA vs PFO Comparison
Compare BMEA & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- PFO
- Stock Information
- Founded
- BMEA 2017
- PFO 1991
- Country
- BMEA United States
- PFO United States
- Employees
- BMEA N/A
- PFO N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- PFO Finance Companies
- Sector
- BMEA Health Care
- PFO Finance
- Exchange
- BMEA Nasdaq
- PFO Nasdaq
- Market Cap
- BMEA 153.3M
- PFO 123.7M
- IPO Year
- BMEA 2021
- PFO N/A
- Fundamental
- Price
- BMEA $4.19
- PFO $9.08
- Analyst Decision
- BMEA Buy
- PFO
- Analyst Count
- BMEA 13
- PFO 0
- Target Price
- BMEA $37.25
- PFO N/A
- AVG Volume (30 Days)
- BMEA 1.1M
- PFO 31.8K
- Earning Date
- BMEA 10-29-2024
- PFO 01-01-0001
- Dividend Yield
- BMEA N/A
- PFO 6.51%
- EPS Growth
- BMEA N/A
- PFO N/A
- EPS
- BMEA N/A
- PFO N/A
- Revenue
- BMEA N/A
- PFO N/A
- Revenue This Year
- BMEA N/A
- PFO N/A
- Revenue Next Year
- BMEA N/A
- PFO N/A
- P/E Ratio
- BMEA N/A
- PFO N/A
- Revenue Growth
- BMEA N/A
- PFO N/A
- 52 Week Low
- BMEA $3.61
- PFO $6.90
- 52 Week High
- BMEA $20.21
- PFO $8.51
- Technical
- Relative Strength Index (RSI)
- BMEA 24.17
- PFO 40.11
- Support Level
- BMEA $3.81
- PFO $9.01
- Resistance Level
- BMEA $6.06
- PFO $9.28
- Average True Range (ATR)
- BMEA 0.56
- PFO 0.09
- MACD
- BMEA -0.14
- PFO -0.01
- Stochastic Oscillator
- BMEA 7.40
- PFO 25.81
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.